Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study

BACKGROUND: Little is known about vaccine effectiveness over time among adolescents, especially against the SARS-CoV-2 omicron (B.1.1.529) variant. This study assessed the associations between time since two-dose vaccination with BNT162b2 and the occurrence of symptomatic SARS-CoV-2 infection and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Florentino, Pilar T V, Millington, Tristan, Cerqueira-Silva, Thiago, Robertson, Chris, de Araújo Oliveira, Vinicius, Júnior, Juracy B S, Alves, Flávia J O, Penna, Gerson O, Vital Katikireddi, Srinivasa, Boaventura, Viviane S, Werneck, Guilherme L, Pearce, Neil, McCowan, Colin, Sullivan, Christopher, Agrawal, Utkarsh, Grange, Zoe, Ritchie, Lewis D, Simpson, Colin R, Sheikh, Aziz, Barreto, Mauricio L, Rudan, Igor, Barral-Netto, Manoel, Paixão, Enny S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359673/
https://www.ncbi.nlm.nih.gov/pubmed/35952702
http://dx.doi.org/10.1016/S1473-3099(22)00451-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359673/
https://www.ncbi.nlm.nih.gov/pubmed/35952702
http://dx.doi.org/10.1016/S1473-3099(22)00451-0

Ejemplares similares